Accordingly, several human and animal studies have demonstrated that exogenous Cr administration improves glucose tolerance and insulin sensitivity in type 2 diabetes and obesity [23,24,25]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.